ADAP - Adaptimmune GAAP EPS of -$0.05 beats by $0.19 revenue of $3.6M misses by $1.4M May, 09 2022 07:32 AM Adaptimmune Therapeutics plc Adaptimmune press release (NASDAQ:ADAP): Q1 GAAP EPS of -$0.05 beats by $0.19. Revenue of $3.6M (+737.2% Y/Y) misses by $1.4M. For further details see: Adaptimmune GAAP EPS of -$0.05 beats by $0.19, revenue of $3.6M misses by $1.4M